Search research articles
Contact Us
Filters
Showing results (81-90 of 284) with videos related to
Page
of 29
Sort By:
American Journal of Preventive Cardiology
|
April 4, 2022
Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update
Jing Gu, Robert Sanchez, Ankita Chauhan, et al.
Journal of the American College of Cardiology
|
July 18, 2018
The Evolving Future of PCSK9 Inhibitors
Robert S Rosenson, Robert A Hegele, Sergio Fazio, et al.
Endocrine Reviews
|
October 13, 2018
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B Sandesara, Salim S Virani, Sergio Fazio, et al.
Metabolism: Clinical and Experimental
|
February 1, 2018
Balanced high fat diet reduces cardiovascular risk in obese women although changes in adipose tissue, lipoproteins, and insulin resistance differ by race
Kevin D Niswender, Sergio Fazio, Barbara A Gower, et al.
Diabetes, Obesity & Metabolism
|
September 19, 2018
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol
Gregory A Nichols, Sephy Philip, Kristi Reynolds, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 2018
Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol
Gregory A Nichols, Sephy Philip, Kristi Reynolds, et al.
Journal of the American College of Cardiology
|
January 29, 2025
Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution
Doron Zahger, Gregory G Schwartz, Michael Szarek, et al.
Cardiovascular Research
|
August 7, 2016
Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
Giuseppe Danilo Norata, Hagai Tavori, Angela Pirillo, et al.
Journal of Clinical Lipidology
|
November 1, 2022
Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease
Jing Gu, Robert J Sanchez, Ankita Chauhan, et al.
The Journal of Biological Chemistry
|
October 27, 2011
Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein
Fen Du, Yvonne Hui, Michelle Zhang, et al.
Page
of 29
Search research articles
Search
Showing results (81-90 of 284) with videos related to
Sort By:
Page
of 29
American Journal of Preventive Cardiology
|
April 4, 2022
Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update
Jing Gu, Robert Sanchez, Ankita Chauhan, et al.
Journal of the American College of Cardiology
|
July 18, 2018
The Evolving Future of PCSK9 Inhibitors
Robert S Rosenson, Robert A Hegele, Sergio Fazio, et al.
Endocrine Reviews
|
October 13, 2018
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B Sandesara, Salim S Virani, Sergio Fazio, et al.
Metabolism: Clinical and Experimental
|
February 1, 2018
Balanced high fat diet reduces cardiovascular risk in obese women although changes in adipose tissue, lipoproteins, and insulin resistance differ by race
Kevin D Niswender, Sergio Fazio, Barbara A Gower, et al.
Diabetes, Obesity & Metabolism
|
September 19, 2018
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol
Gregory A Nichols, Sephy Philip, Kristi Reynolds, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 2018
Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol
Gregory A Nichols, Sephy Philip, Kristi Reynolds, et al.
Journal of the American College of Cardiology
|
January 29, 2025
Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution
Doron Zahger, Gregory G Schwartz, Michael Szarek, et al.
Cardiovascular Research
|
August 7, 2016
Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
Giuseppe Danilo Norata, Hagai Tavori, Angela Pirillo, et al.
Journal of Clinical Lipidology
|
November 1, 2022
Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease
Jing Gu, Robert J Sanchez, Ankita Chauhan, et al.
The Journal of Biological Chemistry
|
October 27, 2011
Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein
Fen Du, Yvonne Hui, Michelle Zhang, et al.
Page
of 29